Home
TimeZone
   
Currency
   
Language
  HOME   STOCK MARKETS PORTFOLIO WATCHLIST ALERTS INDICES CONVERTER IR SERVICES MORE


Back
10 Last viewed shares   
 
Year in Brief
  Year in Brief
  2014 Main Highlights January Launched renal anemia treatment NESP ® Injection 5μg Plastic Syringe in Japan February Added new information covering pollinosis ...
  Read more... 
Strategy & Goals
  Strategy & Goals
  Corporate Strategy Össur’s vision is to be the leading company in non-invasive orthopaedics. Össur’s business is improving people’s mobility through ...
  Read more... 
Year in Brief
  Year in Brief
  REVENUE The consolidated revenue of the Group for the year 2018 amounted to approximately RMB 740,422,000, comparing to approximately RMB 497,694,000 for the ...
  Read more... 
   

Amgen, Inc.

    Print this page Print this page    Send to a Friend E-mail this page to your friend    Disclaimer

SHARE DATA GRAPH TECHNICAL ANALYSIS
Select class of Share
Amgen (WB) (VSE)‎  
Last 256,30      Change % 0,00 
Add to Portfolio
Add to Watchlist
Add to Alerts

10 LAST TRADES EUR
Time Last Volume
Displayed time is based on the time zone of your choice on Euroland.com
Refresh
ChartImage
 
QUOTES EUR
Time 2024-04-24
Last 256,30
Change % 0,00 
Change 0,00 
Bid/Ask 220,70 / 221,40
Open 254,00
High/Low 256,30 / 252,05
Volume 0
Previous Close 256,30
52 Weeks High 265,20
52 Weeks Low 215,75
52 Weeks %   18,52 
YTD %   18,52 
Volatility 26,62
Beta N/A
Correlation N/A
MARKET DATA
Symbol AMGN
Market  Vienna
List  Global Market
Domestic Industry  Biotechnology
Euroland-Industry  Biotechnology
Shares (mil)1 535,18
Market Cap (mil) 137 166,13
1 - Number of shares in specific class of share. Otherwise it is total number of shares issued.

INDICES
 -
Data delayed at least 15 minutes. From Hanoi & HoChiMinh data is real time. From Milan, Dublin & Tokyo data is as end of day.
Data provided by vwd group Switzerland AG & MOEX.

 
 
   Privacy Policy | Disclaimer | Set this page as your homepage| © Euroland.com 2000-2024